These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 17267790)

  • 21. Preliminary evidence for cognitive mediation during cognitive-behavioral therapy of panic disorder.
    Hofmann SG; Meuret AE; Rosenfield D; Suvak MK; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Consult Clin Psychol; 2007 Jun; 75(3):374-9. PubMed ID: 17563154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can pill placebo augment cognitive-behavior therapy for panic disorder?
    Furukawa TA; Watanabe N; Omori IM; Churchill R
    BMC Psychiatry; 2007 Dec; 7():73. PubMed ID: 18093337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive-behavior therapy versus pharmacotherapy: Now that the jury's returned its verdict, it's time to present the rest of the evidence.
    Jacobson NS; Hollon SD
    J Consult Clin Psychol; 1996 Feb; 64(1):74-80. PubMed ID: 8907086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipramine-Induced Cutaneous and Iris Hyperpigmentation: A Case Report and Literature Review.
    Coffey N; Ali Z; Grau J
    Prim Care Companion CNS Disord; 2022 Mar; 24(2):. PubMed ID: 35364629
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy.
    Marcus SM; Gorman J; Shear MK; Lewin D; Martinez J; Ray S; Goetz R; Mosovich S; Gorman L; Barlow D; Woods S
    Am J Psychiatry; 2007 Feb; 164(2):273-5. PubMed ID: 17267790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Panic disorder: long-term pharmacotherapy and discontinuation.
    Rickels K; Schweizer E
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The drug treatment of panic disorder.
    Matuzas W; Jack E
    Psychiatr Med; 1991; 9(2):215-43. PubMed ID: 1677479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An integrated treatment approach to panic disorder.
    Craske MG
    Bull Menninger Clin; 1996; 60(2 Suppl A):A87-104. PubMed ID: 8857429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imipramine-induced hyperpigmentation: four cases and a review of the literature.
    Ming ME; Bhawan J; Stefanato CM; McCalmont TH; Cohen LM
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):159-66. PubMed ID: 10025739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome.
    Gurguis GN; Blakeley JE; Antai-Otong D; Vo SP; Orsulak PJ; Petty F; Rush AJ
    J Psychiatr Res; 1999; 33(4):309-22. PubMed ID: 10404469
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.